Loading...
Please wait, while we are loading the content...
Similar Documents
Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)
| Content Provider | MDPI |
|---|---|
| Author | Mar, ía Ruiz-Ruigómez Mario, Fernández-Ruiz Ana, Pérez-Ayala Aguado, José María |
| Copyright Year | 2022 |
| Description | COVID-19-associated pulmonary aspergillosis (CAPA) have been documented during the COVID-19 pandemic. The vast majority of these patients do not meet the classic EORTC/MSGERC criteria for invasive pulmonary aspergillosis. The question arises as to whether there may have been an over-diagnosis of this disease. Here we review our experience and analyze the evolution of 27 patients who were diagnosed with CAPA during hospital admission. Surviving patients were followed-up for a mean time of 15 months (SD 3.78) by a group of experts and clinical records of diseased patients were reviewed. After expert evaluation and follow-up, 10 patients were finally assumed as CAPA according to expert opinion. These cases represent 40% of the initially CAPA assumed cases. Our data suggest the need to reconsider actual diagnosis criteria for CAPA what could drive to better identification of these patients. |
| Starting Page | 840 |
| e-ISSN | 2309608X |
| DOI | 10.3390/jof8080840 |
| Journal | Journal of Fungi |
| Issue Number | 8 |
| Volume Number | 8 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2022-08-11 |
| Access Restriction | Open |
| Subject Keyword | Journal of Fungi Infectious Diseases Covid-19-associated Pulmonary Aspergillosis (capa) Pulmonary Aspergillosis Antifungal |
| Content Type | Text |
| Resource Type | Article |
